{
  "symbol": "ABBV",
  "date": "2025-10-05",
  "headlines": [
    {
      "date": "2025-10-03",
      "time": "16:55",
      "title": "5 Large Cap Drug Stocks: Values or Traps?\n\n\n(Zacks)",
      "link": "/news/183710/5-large-cap-drug-stocks-values-or-traps"
    },
    {
      "date": "2025-10-05",
      "time": "09:59AM",
      "title": "Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?\n\n\n(Zacks)",
      "link": "/news/183437/is-pfe-stock-a-buy-after-14-rise-post-drug-pricing-deal-with-trump"
    },
    {
      "date": "2025-10-05",
      "time": "08:03AM",
      "title": "How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment\n\n\n(Investor's Business Daily)",
      "link": "https://www.investors.com/research/the-new-america/beone-medicines-beigene-cancer-treatment?mod=IBD_FV"
    },
    {
      "date": "2025-10-05",
      "time": "06:27AM",
      "title": "Bernstein Remains a Hold on AbbVie Inc. (ABBV)\n\n\n(Insider Monkey)",
      "link": "/news/183081/bernstein-remains-a-hold-on-abbvie-inc-abbv"
    },
    {
      "date": "2025-10-05",
      "time": "12:38AM",
      "title": "2 Healthcare Stocks to Research Further and 1 Facing Challenges\n\n\n(StockStory)",
      "link": "/news/182921/2-healthcare-stocks-to-research-further-and-1-facing-challenges"
    },
    {
      "date": "2025-10-02",
      "time": "17:45",
      "title": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why\n\n\n(Zacks)",
      "link": "/news/182795/abbvie-abbv-stock-sinks-as-market-gains-heres-why"
    },
    {
      "date": "2025-10-05",
      "time": "09:23AM",
      "title": "Stock Market News for Oct 2, 2025\n\n\n(Zacks)",
      "link": "/news/182347/stock-market-news-for-oct-2-2025"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "AbbVie to Host Third-Quarter 2025 Earnings Conference Call\n\n\n(PR Newswire)",
      "link": "/news/182111/abbvie-to-host-third-quarter-2025-earnings-conference-call"
    },
    {
      "date": "2025-10-05",
      "time": "02:55AM",
      "title": "AbbVie (ABBV) Advances Parkinson's Treatment With Tavapadon NDA\n\n\n(Insider Monkey)",
      "link": "/news/181855/abbvie-abbv-advances-parkinsons-treatment-with-tavapadon-nda"
    },
    {
      "date": "2025-10-05",
      "time": "02:08AM",
      "title": "Leerink Raises AbbVie (ABBV) Price Target on Strong Business Performance\n\n\n(Insider Monkey)",
      "link": "/news/181789/leerink-raises-abbvie-abbv-price-target-on-strong-business-performance"
    },
    {
      "date": "2025-10-01",
      "time": "18:36",
      "title": "Why AbbVie Stock Cruised to an Almost 6% Gain Today\n\n\n(Motley Fool)  +5.55%",
      "link": "/news/181606/why-abbvie-stock-cruised-to-an-almost-6-gain-today"
    },
    {
      "date": "2025-10-05",
      "time": "04:01PM",
      "title": "Why AbbVie (ABBV) Stock Is Trading Up Today\n\n\n(StockStory)",
      "link": "/news/181393/why-abbvie-abbv-stock-is-trading-up-today"
    },
    {
      "date": "2025-10-05",
      "time": "01:57PM",
      "title": "AbbVie's (ABBV) Dividend Track Record: A Testament to Stability\n\n\n(Insider Monkey)",
      "link": "/news/181299/abbvies-abbv-dividend-track-record-a-testament-to-stability"
    },
    {
      "date": "2025-10-05",
      "time": "11:37AM",
      "title": "AbbVie breaks ground on $70m US biologics site amid Trump pressure\n\n\n(Pharmaceutical Technology)",
      "link": "https://finance.yahoo.com/m/b5cee3f0-3a5f-3742-ab17-09fe511a3596/abbvie-breaks-ground-on-%2470m.html"
    },
    {
      "date": "2025-10-05",
      "time": "10:15AM",
      "title": "AbbVie Stock Is Just What the Doctor Ordered\n\n\n(Barchart)",
      "link": "https://finance.yahoo.com/m/f491ed3a-ce89-39e4-8846-71e63b0fd5bd/abbvie-stock-is-just-what-the.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:22AM",
      "title": "Company News for Oct 1, 2025\n\n\n(Zacks)",
      "link": "/news/180948/company-news-for-oct-1-2025"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "Natrelle Awarded Supplier Agreement from Vizient\n\n\n(PR Newswire)",
      "link": "/news/180693/natrelle-awarded-supplier-agreement-from-vizient"
    },
    {
      "date": "2025-10-05",
      "time": "05:31AM",
      "title": "Bristol Myers, Takeda to pool data for AI-based drug discovery\n\n\n(Reuters)",
      "link": "https://finance.yahoo.com/news/bristol-myers-takeda-pool-data-093127023.html"
    },
    {
      "date": "2025-10-05",
      "time": "05:25AM",
      "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever\n\n\n(Motley Fool)",
      "link": "/news/180524/want-decades-of-passive-income-3-stocks-to-buy-now-and-hold-forever"
    },
    {
      "date": "2025-09-30",
      "time": "16:05",
      "title": "AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know\n\n\n(StockStory)",
      "link": "/news/180135/abbvie-amn-healthcare-services-lemaitre-waters-corporation-and-organon-shares-skyrocket-what-you-need-to-know"
    },
    {
      "date": "2025-10-05",
      "time": "03:00PM",
      "title": "AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.\n\n\n(PR Newswire)",
      "link": "/news/180036/abbvie-begins-construction-on-70-million-expansion-to-further-increase-biologics-manufacturing-and-rd-presence-in-the-us"
    },
    {
      "date": "2025-10-05",
      "time": "11:47AM",
      "title": "Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/5d8a361e-7039-366b-a5d8-1723528a8ca2/pfizer-stock-rises-after-wsj.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:00AM",
      "title": "AbbVie Inc.(ABBV) Unit Expands Skin Solution Availability amid $5.2B Opportunity\n\n\n(Insider Monkey)",
      "link": "/news/179048/abbvie-incabbv-unit-expands-skin-solution-availability-amid-52b-opportunity"
    },
    {
      "date": "2025-09-29",
      "time": "14:36",
      "title": "AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease\n\n\n(Zacks)",
      "link": "/news/178739/abbvie-seeks-fda-nod-for-tavapadon-to-treat-parkinsons-disease"
    },
    {
      "date": "2025-10-05",
      "time": "12:00PM",
      "title": "AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility\n\n\n(PR Newswire)",
      "link": "/news/178575/abbvie-breaks-ground-on-new-north-chicago-active-pharmaceutical-ingredient-manufacturing-facility"
    },
    {
      "date": "2025-10-05",
      "time": "09:11AM",
      "title": "AbbVie to launch ovarian cancer drug in UK at US price\n\n\n(Reuters)",
      "link": "https://finance.yahoo.com/news/abbvie-launch-ovarian-cancer-drug-131105863.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:00AM",
      "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know\n\n\n(Zacks)",
      "link": "/news/178394/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know"
    },
    {
      "date": "2025-10-05",
      "time": "09:00AM",
      "title": "AbbVie Announces UK Pricing Strategy for ELAHERE (mirvetuximab soravtansine-gynx)\n\n\n(PR Newswire)",
      "link": "/news/178285/abbvie-announces-uk-pricing-strategy-for-elahere-mirvetuximab-soravtansine-gynx"
    },
    {
      "date": "2025-10-05",
      "time": "04:42AM",
      "title": "1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now\n\n\n(Motley Fool)",
      "link": "/news/177942/1-top-etf-i-wouldnt-hesitate-to-invest-1000-into-right-now"
    },
    {
      "date": "2025-09-28",
      "time": "10:00",
      "title": "5 Dividend Powerhouses to Buy and Never Sell\n\n\n(Motley Fool)",
      "link": "/news/177701/5-dividend-powerhouses-to-buy-and-never-sell"
    },
    {
      "date": "2025-09-26",
      "time": "16:51",
      "title": "Eli Lilly, Pfizer, Amgen Stocks Rise After Trumps 100% Pharma Tariff Threat. Heres Why.\n\n\n(Barrons.com)",
      "link": "https://finance.yahoo.com/m/56f949c4-0da7-3f93-bd14-99e92ada288d/eli-lilly%2C-pfizer%2C-amgen.html"
    },
    {
      "date": "2025-10-05",
      "time": "11:45AM",
      "title": "Has AbbVie Successfully Navigated Top-line Growth Post Humira LOE?\n\n\n(Zacks)",
      "link": "/news/177170/has-abbvie-successfully-navigated-top-line-growth-post-humira-loe"
    },
    {
      "date": "2025-10-05",
      "time": "09:58AM",
      "title": "Trump's new tariffs on pharma, furniture, & trucks: What to know\n\n\n(Yahoo Finance Video)",
      "link": "https://finance.yahoo.com/video/trumps-tariffs-pharma-furniture-trucks-135821259.html"
    },
    {
      "date": "2025-10-05",
      "time": "08:45AM",
      "title": "AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease\n\n\n(PR Newswire)",
      "link": "/news/176719/abbvie-submits-new-drug-application-to-us-fda-for-tavapadon-for-the-treatment-of-parkinsons-disease"
    },
    {
      "date": "2025-10-05",
      "time": "08:15AM",
      "title": "Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why.\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/eli-lilly-pfizer-stock-trump-pharma-tariffs-2b9ddfb7?mod=bar_FV"
    },
    {
      "date": "2025-09-25",
      "time": "05:00",
      "title": "Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai\n\n\n(PR Newswire)",
      "link": "/news/175344/allergan-aesthetics-to-showcase-multimodal-treatment-approach-and-continued-commitment-to-skin-quality-at-amwc-dubai"
    },
    {
      "date": "2025-10-05",
      "time": "05:00AM",
      "title": "3 Top Dividend Stocks to Buy and Hold Forever\n\n\n(Motley Fool)",
      "link": "/news/175368/3-top-dividend-stocks-to-buy-and-hold-forever"
    },
    {
      "date": "2025-10-05",
      "time": "04:44AM",
      "title": "Where Will AbbVie Be in 5 Years?\n\n\n(Motley Fool)",
      "link": "/news/175348/where-will-abbvie-be-in-5-years"
    },
    {
      "date": "2025-09-24",
      "time": "17:45",
      "title": "AbbVie (ABBV) Declines More Than Market: Some Information for Investors\n\n\n(Zacks)",
      "link": "/news/175107/abbvie-abbv-declines-more-than-market-some-information-for-investors"
    },
    {
      "date": "2025-09-23",
      "time": "14:47",
      "title": "These Dividend Stocks Have Big Yields and Are Beating the Odds\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/dividend-stocks-big-yields-seagate-newsmont-tapestry-cvs-a1384d06?mod=bar_FV"
    },
    {
      "date": "2025-10-05",
      "time": "05:00AM",
      "title": "Allergan Aesthetics Announces Expansion of SKINVIVE by JUVEDERM into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality\n\n\n(PR Newswire)",
      "link": "/news/172933/allergan-aesthetics-announces-expansion-of-skinvive-by-juvederm-into-35-new-markets-reinforcing-its-commitment-to-advancing-global-skin-quality"
    },
    {
      "date": "2025-09-22",
      "time": "21:20",
      "title": "1 Top Dividend Stock to Buy and Hold Forever\n\n\n(Motley Fool)",
      "link": "/news/172874/1-top-dividend-stock-to-buy-and-hold-forever"
    },
    {
      "date": "2025-10-05",
      "time": "05:31PM",
      "title": "Piper Sandler Reiterates Its 'Overweight' Rating on AbbVie Inc. (ABBV) with a $231 PT\n\n\n(Insider Monkey)",
      "link": "/news/172700/piper-sandler-reiterates-its-overweight-rating-on-abbvie-inc-abbv-with-a-231-pt"
    },
    {
      "date": "2025-10-05",
      "time": "11:13AM",
      "title": "What Is One of the Best Pharmaceutical Stocks to Buy Right Now?\n\n\n(Motley Fool)",
      "link": "/news/172420/what-is-one-of-the-best-pharmaceutical-stocks-to-buy-right-now"
    },
    {
      "date": "2025-10-05",
      "time": "04:46AM",
      "title": "Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell\n\n\n(Motley Fool)",
      "link": "/news/171879/forever-dividend-stocks-3-income-stocks-i-never-plan-to-sell"
    },
    {
      "date": "2025-09-21",
      "time": "09:19",
      "title": "AbbVie Inc. (ABBV) Extends Rinvoq Patent to 2037, Delaying Generics\n\n\n(Insider Monkey)",
      "link": "/news/171642/abbvie-inc-abbv-extends-rinvoq-patent-to-2037-delaying-generics"
    },
    {
      "date": "2025-09-20",
      "time": "23:18",
      "title": "Dividend Paying Stocks With Stability: AbbVie's (ABBV) Consistent Record\n\n\n(Insider Monkey)",
      "link": "/news/171505/dividend-paying-stocks-with-stability-abbvies-abbv-consistent-record"
    },
    {
      "date": "2025-10-05",
      "time": "05:30AM",
      "title": "The Years Biggest Deal Could Yield a Record Payout for Bank of America\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/693de84b-69f7-3d02-81cb-94c6c8023595/the-year%E2%80%99s-biggest-deal-could.html"
    },
    {
      "date": "2025-09-19",
      "time": "12:03",
      "title": "Boost Your Portfolio With These Top-Ranked ETFs\n\n\n(Zacks)",
      "link": "/news/171005/boost-your-portfolio-with-these-top-ranked-etfs"
    },
    {
      "date": "2025-10-05",
      "time": "08:59AM",
      "title": "Analyst Report: AbbVie Inc.\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/e99f25d1-cb8f-35db-80ac-a8d669a65599/analyst-report%3A-abbvie-inc..html"
    },
    {
      "date": "2025-10-05",
      "time": "08:59AM",
      "title": "The Zacks Analyst Blog Highlights AbbVie, ServiceNow, Boeing, Tucows and and Ampco-Pittsburgh\n\n\n(Zacks)",
      "link": "/news/170742/the-zacks-analyst-blog-highlights-abbvie-servicenow-boeing-tucows-and-and-ampco-pittsburgh"
    },
    {
      "date": "2025-10-05",
      "time": "04:44AM",
      "title": "3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off\n\n\n(Motley Fool)",
      "link": "/news/170336/3-unstoppable-dividend-stocks-to-buy-if-theres-a-stock-market-sell-off"
    },
    {
      "date": "2025-09-18",
      "time": "16:15",
      "title": "Top Analyst Reports for AbbVie, ServiceNow & Boeing\n\n\n(Zacks)",
      "link": "/news/170060/top-analyst-reports-for-abbvie-servicenow-boeing"
    },
    {
      "date": "2025-10-05",
      "time": "11:30AM",
      "title": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why\n\n\n(Zacks)",
      "link": "/news/169846/jj-expects-innovative-medicines-growth-despite-stelara-loe-heres-why"
    },
    {
      "date": "2025-10-05",
      "time": "11:04AM",
      "title": "BMO Lifts AbbVie Inc. (ABBV) Price Target to $240 After Rinvoq Litigation Win\n\n\n(Insider Monkey)",
      "link": "/news/169699/bmo-lifts-abbvie-inc-abbv-price-target-to-240-after-rinvoq-litigation-win"
    },
    {
      "date": "2025-09-17",
      "time": "17:45",
      "title": "AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note\n\n\n(Zacks)",
      "link": "/news/168999/abbvie-abbv-ascends-while-market-falls-some-facts-to-note"
    },
    {
      "date": "2025-10-05",
      "time": "04:11PM",
      "title": "Oruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest Moneymaker\n\n\n(Investor's Business Daily)",
      "link": "https://www.investors.com/news/technology/oruka-therapeutics-biotech-stock-psoriasis-treatment?mod=IBD_FV"
    },
    {
      "date": "2025-10-05",
      "time": "02:17PM",
      "title": "Calls of the Day: Netflix, Disney, Walmart and AbbVie\n\n\n(CNBC TV)",
      "link": "https://www.youtube.com/watch?v=6x7r3VhuK_g"
    },
    {
      "date": "2025-10-05",
      "time": "12:54PM",
      "title": "Should You Buy This Blue-Chip Dividend Stock at Record Highs?\n\n\n(Barchart)",
      "link": "https://finance.yahoo.com/m/fc114115-dd8f-31b5-880e-3bf9bd078d95/should-you-buy-this-blue-chip.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:33AM",
      "title": "Netflix upgraded, Five Below initiated: Wall Street's top analyst calls\n\n\n(The Fly)",
      "link": "https://finance.yahoo.com/news/netflix-upgraded-five-below-initiated-133319822.html"
    },
    {
      "date": "2025-09-16",
      "time": "14:58",
      "title": "Guggenheim Reiterates a Buy Rating on AbbVie (ABBV), Sets a PT of $227\n\n\n(Insider Monkey)",
      "link": "/news/167786/guggenheim-reiterates-a-buy-rating-on-abbvie-abbv-sets-a-pt-of-227"
    },
    {
      "date": "2025-10-05",
      "time": "10:51AM",
      "title": "Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?\n\n\n(Zacks)",
      "link": "/news/167493/is-abbv-stock-a-buy-hold-or-sell-after-its-almost-23-rise-ytd"
    },
    {
      "date": "2025-10-05",
      "time": "09:54AM",
      "title": "AbbVie (ABBV)'s Dividend Track Record: How It Became a Leader in Consistent Dividends\n\n\n(Insider Monkey)",
      "link": "/news/167227/abbvie-abbvs-dividend-track-record-how-it-became-a-leader-in-consistent-dividends"
    },
    {
      "date": "2025-09-13",
      "time": "06:42",
      "title": "3 No-Brainer Dividend Stocks to Buy in September\n\n\n(Motley Fool)",
      "link": "/news/165446/3-no-brainer-dividend-stocks-to-buy-in-september"
    },
    {
      "date": "2025-09-12",
      "time": "20:14",
      "title": "Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/4b001331-18b1-3241-8397-807079689f87/morningstar-%7C-a-weekly.html"
    },
    {
      "date": "2025-10-05",
      "time": "01:48PM",
      "title": "AbbVie Shares Hit Record High on Rinvoq Exclusivity Extension to 2037\n\n\n(GuruFocus.com)",
      "link": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-174815473.html"
    },
    {
      "date": "2025-10-05",
      "time": "01:30PM",
      "title": "1 Green Flag for AbbVie (ABBV) Stock Right Now\n\n\n(Motley Fool)",
      "link": "/news/165187/1-green-flag-for-abbvie-abbv-stock-right-now"
    },
    {
      "date": "2025-10-05",
      "time": "12:11PM",
      "title": "Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.\n\n\n(Barrons.com)",
      "link": "https://finance.yahoo.com/m/58217ebd-d4b9-3fe5-8cfc-9309aa8f127e/prescription-drug-ads-face.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:57AM",
      "title": "AbbVie Stock Hit a Record on 'Big Win' for Blockbuster Drug. The Case for Buying In.\n\n\n(Barrons.com)",
      "link": "https://www.barrons.com/articles/abbvie-stock-rinvoq-7b5684a3?mod=bar_FV"
    },
    {
      "date": "2025-10-05",
      "time": "09:21AM",
      "title": "AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock\n\n\n(Zacks)",
      "link": "/news/164901/abbvie-settles-rinvoq-patent-dispute-what-it-means-for-the-stock"
    },
    {
      "date": "2025-10-05",
      "time": "09:18AM",
      "title": "Company News for Sep 12, 2025\n\n\n(Zacks)",
      "link": "/news/164898/company-news-for-sep-12-2025"
    },
    {
      "date": "2025-10-05",
      "time": "08:55AM",
      "title": "AbbVie settles litigation with all generic manufacturers of Rinvoq\n\n\n(TipRanks)",
      "link": "https://finance.yahoo.com/news/abbvie-settles-litigation-generic-manufacturers-125538683.html"
    },
    {
      "date": "2025-10-05",
      "time": "07:25AM",
      "title": "AbbVie extends Rinvoq exclusivity by four years after generics settlements\n\n\n(Pharmaceutical Technology)",
      "link": "https://finance.yahoo.com/m/c8ae343e-a14f-3880-8b46-3aa872316fde/abbvie-extends-rinvoq.html"
    },
    {
      "date": "2025-10-05",
      "time": "04:46AM",
      "title": "The Best Stocks to Invest $50,000 In Right Now\n\n\n(Motley Fool)",
      "link": "/news/164525/the-best-stocks-to-invest-50000-in-right-now"
    },
    {
      "date": "2025-09-11",
      "time": "18:48",
      "title": "Analyst Report: AbbVie Inc.\n\n\n(Morningstar Research)",
      "link": "https://finance.yahoo.com/m/0297024f-a595-3c9b-8da4-ab2ffa2a56aa/analyst-report%3A-abbvie-inc..html"
    },
    {
      "date": "2025-10-05",
      "time": "03:43PM",
      "title": "Prescription Drug Ads Could Be Changing. These Stocks Could Get Hurt the Most.\n\n\n(Barrons.com)",
      "link": "https://finance.yahoo.com/m/58217ebd-d4b9-3fe5-8cfc-9309aa8f127e/prescription-drug-ads-could.html"
    },
    {
      "date": "2025-10-05",
      "time": "02:10PM",
      "title": "Stocks to Watch Thursday: Warner Bros., Paramount, Opendoor, Alibaba\n\n\n(The Wall Street Journal)",
      "link": "https://finance.yahoo.com/m/7db1d06b-8646-36f4-b336-4e2c1758b485/stocks-to-watch-thursday%3A.html"
    },
    {
      "date": "2025-10-05",
      "time": "01:30PM",
      "title": "Warren Buffett wouldnt worry about cash if he retired with just $1M  heres why and how to copy his strategy\n\n\n(Moneywise)",
      "link": "https://finance.yahoo.com/news/warren-buffett-wouldn-t-worry-173000008.html"
    },
    {
      "date": "2025-10-05",
      "time": "12:45PM",
      "title": "SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag\n\n\n(Zacks)",
      "link": "/news/164127/snys-gene-therapy-candidate-for-eye-disease-gets-fda-fast-track-tag"
    },
    {
      "date": "2025-10-05",
      "time": "12:24PM",
      "title": "AbbVie shares hit record high as key immunology drug set for exclusivity until 2037\n\n\n(Reuters)",
      "link": "https://finance.yahoo.com/news/abbvie-shares-hit-record-high-162448191.html"
    },
    {
      "date": "2025-10-05",
      "time": "12:17PM",
      "title": "AbbVie in Settlement With Generic Drugmakers on Rinvoq\n\n\n(The Wall Street Journal)",
      "link": "https://www.wsj.com/health/pharma/abbvie-in-settlement-with-generic-drugmakers-on-rinvoq-660ac999?mod=wsj_FV"
    },
    {
      "date": "2025-10-05",
      "time": "11:56AM",
      "title": "Why AbbVie (ABBV) Stock Is Trading Up Today\n\n\n(StockStory)",
      "link": "/news/163979/why-abbvie-abbv-stock-is-trading-up-today"
    },
    {
      "date": "2025-10-05",
      "time": "11:50AM",
      "title": "Why AbbVie Stock Is Jumping Today\n\n\n(Motley Fool)",
      "link": "/news/163984/why-abbvie-stock-is-jumping-today"
    },
    {
      "date": "2025-10-05",
      "time": "11:47AM",
      "title": "AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day\n\n\n(Investor's Business Daily)",
      "link": "https://www.investors.com/news/technology/abbvie-stock-rinvoq-generics-settlement-deal?mod=IBD_FV"
    },
    {
      "date": "2025-10-05",
      "time": "10:27AM",
      "title": "AbbVie stock rises after securing patent protection for RINVOQ until 2037\n\n\n(Investing.com)",
      "link": "https://finance.yahoo.com/news/abbvie-stock-rises-securing-patent-142707645.html"
    },
    {
      "date": "2025-10-05",
      "time": "09:00AM",
      "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It\n\n\n(Zacks)",
      "link": "/news/163678/abbvie-inc-abbv-is-a-trending-stock-facts-to-know-before-betting-on-it"
    },
    {
      "date": "2025-09-09",
      "time": "11:34",
      "title": "LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal\n\n\n(Zacks)",
      "link": "/news/161533/llys-phase-iii-study-on-jaypirca-in-front-line-leukemia-meets-goal"
    },
    {
      "date": "2025-10-05",
      "time": "08:00AM",
      "title": "BOTOX Cosmetic (onabotulinumtoxinA) Unveils \"The One & Only\" Campaign Featuring Real People and Their Distinctive Stories\n\n\n(PR Newswire)",
      "link": "/news/161039/botox-cosmetic-onabotulinumtoxina-unveils-the-one-only-campaign-featuring-real-people-and-their-distinctive-stories"
    },
    {
      "date": "2025-09-08",
      "time": "19:53",
      "title": "This 3 Stock Portfolio Provides Monthly Income\n\n\n(Zacks)",
      "link": "/news/160684/this-3-stock-portfolio-provides-monthly-income"
    },
    {
      "date": "2025-10-05",
      "time": "07:33PM",
      "title": "AbbVie (ABBV) Stock Dips While Market Gains: Key Facts\n\n\n(Zacks)",
      "link": "/news/160675/abbvie-abbv-stock-dips-while-market-gains-key-facts"
    },
    {
      "date": "2025-10-05",
      "time": "02:39PM",
      "title": "Calls of the Day: Abbvie, Vertex, Veeva and Vistra\n\n\n(CNBC TV)",
      "link": "https://www.youtube.com/watch?v=06b7iHAoDdY"
    },
    {
      "date": "2025-10-05",
      "time": "09:42AM",
      "title": "Investing in Oncology: 3 Cancer Stocks With Promising Pipelines\n\n\n(Zacks)",
      "link": "/news/160093/investing-in-oncology-3-cancer-stocks-with-promising-pipelines"
    },
    {
      "date": "2025-10-05",
      "time": "09:15AM",
      "title": "J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?\n\n\n(Zacks)",
      "link": "/news/160051/jj-vs-abbvie-which-healthcare-powerhouse-is-better-positioned"
    },
    {
      "date": "2025-10-05",
      "time": "03:43AM",
      "title": "1 Reason Every Investor Should Know About AbbVie (ABBV)\n\n\n(Motley Fool)",
      "link": "/news/159656/1-reason-every-investor-should-know-about-abbvie-abbv"
    },
    {
      "date": "2025-09-07",
      "time": "04:51",
      "title": "3 Dividend Stocks to Double Up on Right Now\n\n\n(Motley Fool)",
      "link": "/news/159436/3-dividend-stocks-to-double-up-on-right-now"
    },
    {
      "date": "2025-09-06",
      "time": "06:42",
      "title": "3 Stocks to Buy and Hold Forever\n\n\n(Motley Fool)",
      "link": "/news/159413/3-stocks-to-buy-and-hold-forever"
    },
    {
      "date": "2025-09-05",
      "time": "09:07",
      "title": "AbbVie Declares Quarterly Dividend\n\n\n(PR Newswire)",
      "link": "/news/158814/abbvie-declares-quarterly-dividend"
    },
    {
      "date": "2025-09-04",
      "time": "09:17",
      "title": "Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?\n\n\n(Zacks)",
      "link": "/news/157934/will-abbvies-neuroscience-portfolio-continue-to-aid-top-line-growth"
    },
    {
      "date": "2025-10-05",
      "time": "06:41AM",
      "title": "AbbVie and Genmabs Epkinly shows outpatient viability in Phase II trial\n\n\n(Clinical Trials Arena)",
      "link": "https://finance.yahoo.com/m/75b31b0b-fc11-38d3-95f1-d274d4da90ff/abbvie-and-genmab%E2%80%99s-epkinly.html"
    },
    {
      "date": "2025-10-05",
      "time": "05:05AM",
      "title": "Health Canada approves AbbVies Elahere for ovarian cancer\n\n\n(Pharmaceutical Technology)",
      "link": "https://finance.yahoo.com/m/3f842b93-b5c7-3feb-8daa-b40bfa263c55/health-canada-approves.html"
    }
  ]
}